Status:
COMPLETED
Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne
Lead Sponsor:
Galderma Laboratorium GmbH
Conditions:
Acne
Eligibility:
All Genders
12-20 years
Brief Summary
The purpose of this observational study is to assess the efficacy of Epiduo and patient adherence under daily clinical practice conditions in adults and adolescents (12 to 20 years) with moderate infl...
Detailed Description
The objective of this observational study is to assess the efficacy of Epiduo and patient adherence under daily clinical practice conditions in adults and adolescents (12 to 20 years) with moderate in...
Eligibility Criteria
Inclusion
- The patient has been diagnosed with moderate inflammatory acne
- Topical monotherapy of acne with Epiduo is indicated, the decision about treating the patient with Epiduo has been made independently from this study
- The patient is aged between 12 and 20 years
Exclusion
- Pregnancy or breastfeeding
- Hypersensitivity to the medication or any of the ingredients
- Other contraindications mentioned in the Epiduo SPC
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
3113 Patients enrolled
Trial Details
Trial ID
NCT01220102
Start Date
May 1 2010
End Date
November 1 2010
Last Update
February 17 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.